ZBTB2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.417550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
1.709350E-01
Normal-vs-Stage2
1.713410E-01
Normal-vs-Stage3
2.077200E-01
Normal-vs-Stage4
8.632000E-01
Stage1-vs-Stage2
5.366400E-01
Stage1-vs-Stage3
8.184000E-01
Stage1-vs-Stage4
1.138160E-02
Stage2-vs-Stage3
4.782600E-01
Stage2-vs-Stage4
5.318200E-02
Stage3-vs-Stage4
9.218800E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.318780E-01
Normal-vs-AfricanAmerican
7.626600E-01
Normal-vs-Asian
1.340220E-01
Caucasian-vs-AfricanAmerican
1.558360E-01
Caucasian-vs-Asian
3.968800E-01
AfricanAmerican-vs-Asian
1.346190E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.010630E-01
Normal-vs-Female
2.304800E-01
Male-vs-Female
9.966000E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.828200E-01
Normal-vs-Age(41-60Yrs)
2.867600E-01
Normal-vs-Age(61-80Yrs)
1.273630E-01
Normal-vs-Age(81-100Yrs)
3.602600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.847600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.308000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.592600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.868500E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.523420E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.428200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.816200E-02
Normal-vs-Daily Drinker
6.193900E-02
Normal-vs-Weekly Drinker
3.837000E-01
Normal-vs-Occasional Drinker
1.617180E-01
Normal-vs-Social Drinker
2.133800E-01
Non Drinker-vs-Daily Drinker
6.341200E-01
Non Drinker-vs-Weekly Drinker
1.390160E-01
Non Drinker-vs-Occasional Drinker
2.483600E-01
Non Drinker-vs-Social Drinker
3.772400E-01
Daily Drinker-vs-Weekly Drinker
1.078450E-01
Daily Drinker-vs-Occasional Drinker
1.600600E-01
Daily Drinker-vs-Social Drinker
2.607200E-01
Weekly Drinker-vs-Occasional Drinker
6.304600E-01
Weekly Drinker-vs-Social Drinker
6.020000E-01
Occasional Drinker-vs-Social Drinker
9.008800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.772200E-01
Normal-vs-Grade 2
8.544400E-01
Normal-vs-Grade 3
9.000200E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.911700E-02
Grade 1-vs-Grade 3
2.472400E-01
Grade 1-vs-Grade 4
9.772200E-01
Grade 2-vs-Grade 3
3.352000E-01
Grade 2-vs-Grade 4
8.544400E-01
Grade 3-vs-Grade 4
9.000200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.266600E-01
Normal-vs-NonDiabetic
1.044590E-01
Diabetic-vs-NonDiabetic
9.869400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.788400E-01
Normal-vs-NoPancreatitis
1.222430E-01
Pancreatitis-vs-NoPancreatitis
7.980000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.143760E-01
Normal-vs-N1
1.831000E-01
N0-vs-N1
1.829020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.583230E-01
Normal-vs-TP53-NonMutant
2.450400E-01
TP53-Mutant-vs-TP53-NonMutant
9.612000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
